Melatonin overdose lawsuits target manufacturers and individuals who have distributed excessive doses of the hormone supplement, either through mislabeled products that contain far more melatonin than advertised or through unauthorized administration of the substance to unsuspecting users. These lawsuits have emerged from two distinct but related problems: companies systematically overfilling melatonin supplements with dosages that dramatically exceed their labels, and in at least one documented case, a teacher administering melatonin daily to special-needs students without parental knowledge or consent. The scope of melatonin litigation has expanded significantly as regulators and consumers discover the extent of mislabeling in the supplement industry.
In May 2026, a lawsuit was filed against a teacher at Maiden Choice School in Arbutus, Maryland, who allegedly gave students melatonin for at least two months in 2024 without authorization. One 12-year-old student with autism reported experiencing severe nosebleeds, blood clots, and loss of motor functioning as a result. Simultaneously, federal class action lawsuits have targeted major manufacturers including Olly, Procter & Gamble, Zarbee’s, and others for selling melatonin products that far exceeded their advertised dosages—sometimes by more than 200 percent. These lawsuits highlight a critical gap in supplement regulation and raise serious questions about the safety of over-the-counter melatonin products that millions of Americans use without realizing they may be consuming dangerous levels of the hormone.
Table of Contents
- Why Are Melatonin Products Being Sued for Dosage Mislabeling?
- The Broader Problem of Supplement Industry Oversight
- The Maiden Choice School Case and Unauthorized Administration
- Understanding Melatonin Overdose Symptoms and Health Risks
- What Damages Can Melatonin Overdose Lawsuit Plaintiffs Recover?
- Regulatory Response and Calls for Stricter Melatonin Standards
- What You Should Know If You Use Melatonin Products
- Conclusion
Why Are Melatonin Products Being Sued for Dosage Mislabeling?
Melatonin supplement manufacturers have systematically misrepresented the amount of melatonin contained in their products, exposing consumers to doses far exceeding what they believed they were taking. According to a federal class action lawsuit filed against Olly in the U.S. District Court for the Northern District of California, Olly Sleep gummies contained 274 percent more melatonin than advertised on the label. The company’s Immunity Sleep product exceeded its advertised dosage by 165 percent, while Extra Strength Sleep exceeded it by 190 percent. These are not rounding errors or minor discrepancies—they represent deliberate or negligent failures to accurately label products that consumers rely upon for accurate dosing information. Procter & Gamble faces similar allegations regarding its Vicks Pure Zzzs line. According to the class action lawsuit filed in the U.S.
District Court for the Northern District of Illinois, Vicks Pure Zzzs Melatonin gummies contained 163 percent of the advertised dosage, while Pure Zzzs Nightly Sleep tablets exceeded their labeled dose by 150 percent. These dosage discrepancies are particularly concerning because consumers, especially parents giving melatonin to children, rely on product labels to ensure they are administering safe amounts. When a product contains two or three times the labeled dose, the risk of overdose increases proportionally. Independent testing has revealed how widespread the mislabeling problem truly is. Research cited in melatonin litigation shows that 71 percent of tested melatonin products failed to contain melatonin within the legally allowed 10 percent margin of what was claimed on the label. Even more alarming, 26 percent of the products tested contained serotonin—a substance not listed on any of the labels. Serotonin is a neurotransmitter that can cause serious health effects when taken in excess, including serotonin syndrome, a potentially life-threatening condition characterized by rapid heart rate, high blood pressure, muscle rigidity, and confusion.
The Broader Problem of Supplement Industry Oversight
The melatonin mislabeling crisis reflects a fundamental weakness in how dietary supplements are regulated in the United States. Unlike pharmaceutical drugs, which undergo rigorous testing and FDA approval before reaching consumers, supplements can be marketed and sold with minimal pre-market review. The FDA can only take action against a supplement after it reaches the market and safety problems emerge—a reactive rather than proactive approach. This regulatory gap means manufacturers face few incentives to invest in quality control or accurate dosing during production. Melatonin’s status as an over-the-counter supplement rather than a prescription medication has created false confidence among consumers. Many people assume that if a product is available without a prescription and sold in mainstream retailers, it must be safe.
This assumption has proven dangerous. The CDC reported in March 2024 that 11,000 children were treated in emergency rooms between 2019 and 2022 after ingesting unsupervised melatonin. That figure represents only those cases severe enough to warrant emergency care and does not include children who experienced overdose symptoms managed at home or in urgent care settings. The number is even more striking when one considers that melatonin use in children has skyrocketed over the past decade, with parents turning to it as a natural alternative to prescription sleep medications. The melatonin lawsuits reveal that manufacturers including Zarbee’s tested positive for containing more than twice the advertised dosage in their gummies. Force Factor faces pending litigation over similar dosage misrepresentation, and Relaxium was the subject of a 2022 class action lawsuit addressing the same issues. The consistency across manufacturers suggests this is not an isolated quality control failure but rather an industry-wide problem that demands systemic reform.
The Maiden Choice School Case and Unauthorized Administration
One of the most disturbing melatonin overdose incidents surfaced in May 2026 when a lawsuit was filed against a teacher at Maiden Choice School in Arbutus, Baltimore County, Maryland—a school serving students with severe cognitive disabilities. According to the allegations, this teacher gave students melatonin daily for at least two months in 2024 without obtaining parental consent or notifying school administrators. One 12-year-old student with autism experienced severe nosebleeds, blood clots in his body, and a marked loss of motor functioning after consuming the unauthorized melatonin doses. The case raises troubling questions about access to medications and supplements in school settings, as well as the vulnerability of children with developmental disabilities who may be unable to report unauthorized administration to parents. Baltimore County Public Schools confirmed in a statement that the teacher is no longer employed with the district.
However, as of late May 2026, no criminal charges had been filed, and police had not launched an investigation into the incident. The family’s civil lawsuit remains the primary mechanism for seeking accountability and damages for the child’s injuries. This case demonstrates that melatonin overdose risks are not limited to labeled products with inaccurate dosing information. Even when melatonin comes from legitimate sources, unauthorized or excessive administration can cause serious medical complications. The incident also highlights how persons with authority over vulnerable populations—in this case, a teacher—can exploit their position of trust to administer substances without proper oversight or consent.
Understanding Melatonin Overdose Symptoms and Health Risks
Melatonin overdose produces a range of symptoms that vary depending on the dose, the individual’s age and health status, and the duration of exposure. In mild cases, overdose may cause drowsiness, dizziness, headache, or nausea. However, more significant overdoses can result in serious complications including the nosebleeds and blood clotting problems documented in the Baltimore County school case. Some users have reported hypothermia, loss of consciousness, seizures, and cardiovascular complications from excessive melatonin exposure. The problem is compounded by the fact that many consumers do not realize they are taking dangerous doses because of mislabeling.
A person taking what they believe is a single 5 mg dose may actually be consuming 15 mg or more, and this confusion can extend over weeks or months. Children are particularly vulnerable because their bodies process melatonin differently than adults, and their smaller body weight means any given dose has a proportionally larger effect. The 11,000 pediatric emergency room visits documented by the CDC likely underestimate the true scope of melatonin-related harm, as many cases of overdose or adverse reactions may not result in emergency care. Long-term use of melatonin, particularly at elevated doses, has not been extensively studied in children. Some research suggests that chronic melatonin use may interfere with natural hormonal development during puberty, though this remains an area of ongoing investigation. The lawsuits against melatonin manufacturers are forcing the medical and scientific community to confront the reality that a substance once considered harmless—a naturally occurring hormone available over the counter—can pose genuine risks when mislabeled or misused.
What Damages Can Melatonin Overdose Lawsuit Plaintiffs Recover?
Class action lawsuits against melatonin manufacturers typically seek compensatory damages for injuries caused by overdose, including medical expenses, costs of ongoing treatment, and compensation for pain and suffering. Individual lawsuits, such as the case filed against the Baltimore County teacher, may seek additional punitive damages designed to punish willful misconduct and deter similar behavior in the future. The legal theory behind these cases is that manufacturers either knew or should have known that their products contained excessive melatonin, and that they failed to exercise reasonable care in quality control and labeling. Plaintiffs in the Olly and Vicks Pure Zzzs cases are also pursuing claims for breach of warranty and unjust enrichment, arguing that they paid for a product that did not match its label and were therefore deceived.
If these lawsuits succeed, consumers who purchased these products may be eligible for refunds or settlement payments. However, the amounts vary significantly depending on the number of claimants, the severity of injuries documented, and whether the judge or jury determines that the manufacturer acted intentionally or negligently. It is important to note that proving causation in melatonin overdose cases can be complex. A plaintiff must establish not only that they were exposed to an excessive dose but also that this exposure directly caused their documented injuries. This is easier to establish in cases where the overdose was severe and acute, such as the Baltimore County school case, and more difficult in cases involving chronic low-level overdose where multiple factors may have contributed to health problems.
Regulatory Response and Calls for Stricter Melatonin Standards
The melatonin lawsuits have prompted increased scrutiny from regulatory bodies and lawmakers. In response to the CDC’s March 2024 report on melatonin-related pediatric emergency room visits, there have been calls for the FDA to establish mandatory safety standards and quality control requirements for melatonin supplements. Currently, the FDA does not set specific limits on melatonin dosages or require manufacturers to conduct bioavailability testing to confirm that their products actually contain the advertised amount of the hormone.
Some medical organizations have recommended that melatonin supplements be moved from over-the-counter status to prescription-only availability, particularly for children and adolescents. Others have advocated for warning labels that clearly communicate the risks of overdose and the importance of parental supervision when administering melatonin to minors. The American Academy of Pediatrics has expressed concern about the widespread use of melatonin in children and adolescents without adequate medical supervision or evidence of long-term safety.
What You Should Know If You Use Melatonin Products
If you or your family members currently use melatonin supplements, several steps can help minimize overdose risk while this litigation and regulatory process unfolds. First, purchase melatonin only from reputable manufacturers with transparent quality control practices. Second, start with the lowest possible dose—most adults require far less than 10 mg per night, despite many products offering this dose as standard.
Third, consult with a healthcare provider before giving melatonin to children, as pediatric dosing should be individualized based on the child’s age, weight, and health status. If you have experienced symptoms consistent with melatonin overdose—such as severe headaches, nosebleeds, blood clotting problems, or loss of motor control—after using a melatonin product, consider consulting a physician and reporting the incident to the FDA’s MedWatch program. You may also be eligible to join one of the pending class action lawsuits if you purchased a product from a defendant manufacturer. An attorney specializing in product liability or class action litigation can review your specific situation and advise you regarding your legal options.
Conclusion
Melatonin overdose lawsuits represent a critical moment in the regulation of dietary supplements and the protection of consumers from unsafe products. The combination of systemic mislabeling by manufacturers and the documented case of unauthorized administration to vulnerable students demonstrates that melatonin is not as benign as many consumers have assumed.
The 11,000 children treated in emergency rooms for melatonin-related incidents, combined with independent testing showing that 71 percent of melatonin products exceed their labeled dosages, underscores the need for meaningful regulatory reform and corporate accountability. If you believe you or a family member has been harmed by melatonin overdose or by a mislabeled melatonin product, consult with a class action attorney to understand your rights and potential remedies. The lawsuits against Olly, Procter & Gamble, Zarbee’s, and other manufacturers are ongoing, and settlement opportunities may still be available for eligible plaintiffs.